173 related articles for article (PubMed ID: 35712507)
1. A Novel Prognostic Score Based on Artificial Intelligence in Hepatocellular Carcinoma: A Long-Term Follow-Up Analysis.
Liu X; Wang X; Yu L; Hou Y; Jiang Y; Wang X; Han J; Yang Z
Front Oncol; 2022; 12():817853. PubMed ID: 35712507
[TBL] [Abstract][Full Text] [Related]
2. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.
Liu X; Hou Y; Wang X; Yu L; Wang X; Jiang L; Yang Z
Hepatol Int; 2020 Jul; 14(4):567-576. PubMed ID: 32556865
[TBL] [Abstract][Full Text] [Related]
3. Validation and ranking of seven staging systems of hepatocellular carcinoma.
Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts.
Yu L; Liu X; Wang X; Zhou D; Yan H; Xie Y; Pu Q; Zhang K; Yang Z
Ann Hepatol; 2022; 27(2):100672. PubMed ID: 35065261
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
[TBL] [Abstract][Full Text] [Related]
6. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
[TBL] [Abstract][Full Text] [Related]
8. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
9. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
Front Oncol; 2022; 12():913731. PubMed ID: 36016629
[TBL] [Abstract][Full Text] [Related]
10. Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.
Zhao S; Wang M; Yang Z; Tan K; Zheng D; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):539. PubMed ID: 32411762
[TBL] [Abstract][Full Text] [Related]
11. A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8
Wu Y; Liu X; Wang X; Yu L; Yan H; Xie Y; Pu Q; Cai X; Kong Y; Yang Z
Onco Targets Ther; 2023; 16():753-766. PubMed ID: 37752911
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Artificial Neural Networks for Survival Prediction Model for Patients with Spontaneous Hepatocellular Carcinoma Rupture After Transcatheter Arterial Embolization.
Qiu Y; Wang T; Yang X; Shen S; Yang Y; Wang W
Cancer Manag Res; 2021; 13():7463-7477. PubMed ID: 34611440
[TBL] [Abstract][Full Text] [Related]
13. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
[TBL] [Abstract][Full Text] [Related]
14. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
15. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.
Leung TW; Tang AM; Zee B; Lau WY; Lai PB; Leung KL; Lau JT; Yu SC; Johnson PJ
Cancer; 2002 Mar; 94(6):1760-9. PubMed ID: 11920539
[TBL] [Abstract][Full Text] [Related]
16. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.
Wan G; Gao F; Chen J; Li Y; Geng M; Sun L; Liu Y; Liu H; Yang X; Wang R; Feng Y; Wang X
BMC Cancer; 2017 Jan; 17(1):91. PubMed ID: 28143427
[TBL] [Abstract][Full Text] [Related]
17. Potential of PALBI-T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease.
Tanaka K; Tsuji K; Matsui T; Kang JH; Sakurai Y; Kodama Y; Minami R; Watanabe K; Katanuma A
JGH Open; 2022 Jan; 6(1):36-43. PubMed ID: 35071786
[TBL] [Abstract][Full Text] [Related]
18. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
20. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M
J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
